I have a daughter with endometriosis. A long time sufferer. At a recent appointment with her specialist he claimed that Nextstellis was the 'Gold Standard' contraceptive for endometriosis sufferers.
I still have great hope for Nextstellis, the only problem is that it takes time to build user acceptance and turn that into revenue.
Cheers.....D
Ann: Mayne Pharma to present at HC Wainwright conference in NY, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.02 |
Change
-0.230(4.38%) |
Mkt cap ! $407.8M | |||
| Open | High | Low | Value | Volume |
| $5.17 | $5.18 | $4.95 | $1.129M | 224.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1227 | $5.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.17 | 1580 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |